Originally discovered as an oncogenic coactivator (93), SRC-3 [also known as amplified in breast cancer 1 (AIB1)] is now recognized as a pivotal coactivator for a broad spectrum of physiological processes, ranging from metabolism, circadian rhythms to T cell biology (18, 94–96). Here, NCOA3 is linked to cancer.